Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics

This publication has 67 references indexed in Scilit:

• A novel rat lipoxin A₄ receptor that is conserved in structure and function
  British Journal of Pharmacology, 2003
• Points of control in inflammation
  Nature, 2002
• Aspirin (ASA) regulates 5‐lipoxygenase activity and peroxisome proliferator‐activated receptor α‐mediated CINC‐1 release in rat liver cells: novel actions of lipoxin A₄(LXA₄) and ASA‐triggered 15‐epi‐LXA₄
  The FASEB Journal, 2002
• Lipoxins Induce Actin Reorganization in Monocytes and Macrophages But Not in Neutrophils: Differential Involvement of Rho GTPases
  The American Journal of Pathology, 2002
• 15-Epi-16-(Para-Fluorophenoxy)-Lipoxin A4-Methyl Ester, a Synthetic Analogue of 15-epi-Lipoxin A4, Is Protective in Experimental Ischemic Acute Renal Failure
  Journal of the American Society of Nephrology, 2002
• Identification of Dual Cyclooxygenase–Eicosanoid Oxidoreductase Inhibitors: NSAIDs That Inhibit PG-LX Reductase/LTB4 Dehydrogenase
  Biochemical and Biophysical Research Communications, 2001
• Aspirin‐triggered lipoxin A ₄ and lipoxin A ₄ up‐regulate transcriptional corepressor NAB1 in human neutrophils
  The FASEB Journal, 2001
• Lipoxin A4 Antagonizes the Mitogenic Effects of Leukotriene D4 in Human Renal Mesangial Cells
  Journal of Biological Chemistry, 2000
• Effects of lipoxin A₄ on chemotaxis and degranulation of human eosinophils stimulated by platelet‐activating factor and N‐formyl‐L‐methionyl‐L‐leucyl‐L‐phenylalanine
  Allergy, 1994
• Lipoxin biosynthesis and its impact in inflammatory and vascular events
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994